Redefining Excellence: The Future of Clinical Trial Quality

About this session

Session: WEDNESDAY AFTERNOON PLENARY SESSION: NEW ERA OF RISK/QUALITY (R3) & LEVERAGING AI TO ACCELERATE TRIALS

This keynote explores milestones that have shaped our present approach to clinical trial quality; how standards for excellence are evolving; and what the future holds for clinical trial quality. Patty Leuchten, Founder and CEO of Diligent Pharma, will moderate a fireside chat with industry leaders: Coleen Glessner, Executive Vice President, Quality, Ethics, and Compliance from Emergent BioSolutions; and Shyard Wong, Global Head, Clinical Quality and Continuous Improvement from Sanofi.

Speaker

• CG

  Coleen Glessner

  Speaker